Patent · US Active

Antibodies against 4G7-derived chimeric antigen receptors

US11732041B2 · kind B2 · utility

0Cited by
2References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2020
Grant dateAug 22, 2023
Priority date—
Expiry dateDec 30, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are isolated antibodies that specifically bind anti-CD19 chimeric antigen receptors (CARs) derived from a 4G7 scFv. Also provided are methods of making and using these isolated antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.